glp 1 anesthesia recommendations glp-1 protocol guidelines Are Serious Risks of Semaglutide and Other Agonists Under-Recognized? Case GLP-1 RA guidance roundup -

FDA responded to a health petition and stated it would not object a qualified health claim for omega-3 fatty acids despite concluding that the evidence is inconsistent and inconclusive. One variant of the qualified health claim to which the FDA has not objected reads as follows: Consuming EPA and DHA combined may reduce the risk of CHD (coronary heart disease) by lowering blood pressure. Probiotics Probiotics, which are increasingly recognized for their role in regulating immune activity and reducing inflammation throughout the body, have attracted interest for their ability to reduce LDL cholesterol and cardiovascular risk

However, for patients with chronic kidney disease (CKD) , these medications require careful dosing to avoid risks like dehydration, electrolyte imbalances, and acute kidney injury

L.MenichettiG

10.26402/jpp.2018.3.11 5 Belosic HalleZ.VlainicJ.DrmicD.StrinicD.LueticK.SucicM.et al (2017)

Neuropathy Relief: Prevention and treatment of neurological diseases caused by chemotherapy (e.g., Cisplatin)